Why Shattuck Labs Stock Soared More Than 53% Higher This Week

2026-03-06 17:02:08 ET

Shattuck Labs (NASDAQ: STTK) was an outlier in the healthcare sector this week, thanks mostly to a very well-received earnings report and business update. Over the five trading days, according to data compiled by S&P Global Market Intelligence , the company's shares rose by a very robust 53%.

Shattuck, a clinical-stage biotech that concentrates on developing treatments for inflammatory and immune-mediated disorders, reported its fourth quarter and full-year 2025 results on Thursday.

Image source: Getty Images.

Continue reading